Recruiting National Registry of Rare Kidney Diseases NCT06065852 Conditions AH Amyloidosis, AHL Amyloidosis, AL Amyloidosis, +207 more Locations Zoe Plummer — Bristol, South West, United Kingdom View Trial Details
Not Yet Recruiting Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children NCT06604975 Conditions Behavior, Behavioral Symptoms, Central Diabetes Insipidus, +18 more Locations CHU Angers — Angers, France CHU de Bordeaux — Bordeaux, France CHU Lille — Lille, France HCL — Lyon, France View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration NCT05190744 Conditions Abnormalities, Multiple, Acquired Nephrogenic Diabetes Insipidus, Autosomal Dominant Polycystic Kidney Disease, +19 more Locations Mayo Clinic — Jacksonville, Florida, United States View Trial Details
Completed Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis NCT04939753 Conditions Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Female Urogenital Diseases, +6 more Locations UZ Brussel — Jette, Brussels Capital, Belgium View Trial Details
Completed Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus NCT00478335 Conditions Diabetes Insipidus, Diabetes Insipidus, Nephrogenic, Female Urogenital Diseases, +11 more Locations University of Colorado at Denver and Health Sciences Center — Aurora, Colorado, United States University of Aarhus — Aarhus, Denmark View Trial Details
